Position
Squarepoint Ops LLC in Fennec Pharmaceuticals Inc.
Back to the book · All holders of FENC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$20.3K$7.70 → $6.15
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.1K | $100.9K | — | — | — | 0.0% |
| Q1 2026 | 56.5K | $347.5K | $6.15 | −$20.3K | $266.9K | 0.0% |